GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Pharmaceutical Co Ltd (XKRX:016575.PFD) » Definitions » EV-to-EBITDA

Pacific Pharmaceutical Co (XKRX:016575.PFD) EV-to-EBITDA : 0.00 (As of Jun. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Pacific Pharmaceutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pacific Pharmaceutical Co's enterprise value is ₩0.00 Mil. Pacific Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2012 was ₩8,753.49 Mil. Therefore, Pacific Pharmaceutical Co's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Pacific Pharmaceutical Co's EV-to-EBITDA or its related term are showing as below:

XKRX:016575.PFD's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.495
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-15), Pacific Pharmaceutical Co's stock price is ₩15650.00. Pacific Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2012 was ₩0.000. Therefore, Pacific Pharmaceutical Co's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Pacific Pharmaceutical Co EV-to-EBITDA Historical Data

The historical data trend for Pacific Pharmaceutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Pharmaceutical Co EV-to-EBITDA Chart

Pacific Pharmaceutical Co Annual Data
Trend Dec07 Dec08 Dec09 Dec10
EV-to-EBITDA
- 2.60 3.07 6.29

Pacific Pharmaceutical Co Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.56 2.04 2.21 2.06 3.85

Competitive Comparison of Pacific Pharmaceutical Co's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Pacific Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Pharmaceutical Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pacific Pharmaceutical Co's EV-to-EBITDA falls into.



Pacific Pharmaceutical Co EV-to-EBITDA Calculation

Pacific Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/8753.491
=0.00

Pacific Pharmaceutical Co's current Enterprise Value is ₩0.00 Mil.
Pacific Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,753.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Pharmaceutical Co  (XKRX:016575.PFD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pacific Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15650.00/0.000
=N/A

Pacific Pharmaceutical Co's share price for today is ₩15650.00.
Pacific Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Pacific Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pacific Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Pharmaceutical Co (XKRX:016575.PFD) Business Description

Traded in Other Exchanges
N/A
Address
Website

Pacific Pharmaceutical Co (XKRX:016575.PFD) Headlines

No Headlines